| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $688.9M | — | +11.8% |
| Cost of Revenue | $182.0M | — | +27.4% |
| R&D Expense | $142.7M | — | +7.8% |
| SG&A Expense | $125.3M | — | -6.2% |
| Operating Income | $66.6M | — | +22.4% |
| Pre-tax Income | $79.0M | — | +4.2% |
| Income Tax | $39.0M | — | +55.3% |
| Net Income | $40.0M | — | -21.1% |
| EPS (Basic) | $0.08 | — | -20.0% |
| EPS (Diluted) | $0.08 | — | -20.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $878.4M | +33.5% | -21.5% |
| Short-term Investments | $527.5M | -18.2% | -15.2% |
| Accounts Receivable | $3.32B | -11.8% | +8.9% |
| Current Assets | $4.86B | -7.6% | +0.1% |
| Total Assets | $5.73B | -6.8% | +0.5% |
| Current Liabilities | $2.89B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $391.8M | — | +34.4% |
| Capital Expenditures | $112.7M | — | +90.7% |
| Investing Cash Flow | $466K | — | +100.4% |
| Financing Cash Flow | -$172.1M | — | +58.0% |
| Free Cash Flow | $279.1M | — | +20.1% |
| +7.8% |
| Total Liabilities | $3.28B | -10.6% | +9.8% |
| Stockholders' Equity | $2.45B | -1.2% | -9.7% |